Clinical Trial: A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis

U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07265284) titled 'A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis' on Nov. 24.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of IBI112 in the treatment of adolescent participants with moderate to severe plaque-type psoriasis.

Study Start Date: Dec. 31

Study Type: INTERVENTIONAL

Condition: Psoriasis

Intervention: DRUG: IBI112

IBI112 by subcutaneous injection

DRUG: placebo

placebo by subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Disclaimer: Curated by HT Sy...